ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
42K |
20M |
13 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
42K
|
20M
|
13
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
42K |
20M |
14 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
42K
|
20M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
|
|
muzza111
|
92 |
41K |
12 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
92
|
41K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
10K
|
4.5M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
muzza111
|
130 |
62K |
0 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
130
|
62K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
11 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
10K
|
4.5M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
10K
|
4.5M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
muzza111
|
79 |
37K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
37K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
muzza111
|
316 |
161K |
7 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
316
|
161K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
muzza111
|
947 |
473K |
2 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
947
|
473K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
muzza111
|
315 |
156K |
5 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
156K
|
5
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
muzza111
|
1.6K |
840K |
6 |
10/11/23 |
10/11/23 |
Charts
|
1.6K
|
840K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
17 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
10K
|
4.5M
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
muzza111
|
947 |
473K |
0 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
947
|
473K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
2 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
10K
|
4.5M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
6 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
10K
|
4.5M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
6 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
10K
|
4.5M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor web conference presentation, 14 July 2023
|
|
muzza111
|
35 |
14K |
18 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
35
|
14K
|
18
|
|
ASX - By Stock
|
ARR |
Re:
Ann: Change of Director's Interest Notice
|
|
muzza111
|
30 |
10K |
5 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
30
|
10K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
$4 Target
|
|
muzza111
|
129 |
40K |
10 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
129
|
40K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
2 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
10K
|
4.5M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Wilsons target $18.29 and summary
|
|
muzza111
|
65 |
35K |
1 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
65
|
35K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
muzza111
|
107 |
62K |
24 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
107
|
62K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Petra Capital 12% PT upgrade to $16.26
|
|
muzza111
|
23 |
8.9K |
3 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
23
|
8.9K
|
3
|
|
ASX - By Stock
|
DRE |
Re:
General Discussion
|
|
muzza111
|
2.0K |
982K |
11 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
2.0K
|
982K
|
11
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
muzza111
|
4.0K |
1.3M |
8 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
4.0K
|
1.3M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
muzza111
|
163 |
80K |
9 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
163
|
80K
|
9
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
42K |
20M |
1 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
42K
|
20M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
13 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
10K
|
4.5M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
15 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
10K
|
4.5M
|
15
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
42K |
20M |
8 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
42K
|
20M
|
8
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
42K |
20M |
5 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
42K
|
20M
|
5
|
|
ASX - By Stock
|
AKE |
Re:
EV and battery thread
|
|
muzza111
|
2.1K |
803K |
2 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
2.1K
|
803K
|
2
|
|
ASX - By Stock
|
PLS |
Re:
lithium bubble bursting?
|
|
muzza111
|
70 |
46K |
3 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
70
|
46K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
10K
|
4.5M
|
0
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
42K |
20M |
0 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
42K
|
20M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: FDA approval for Pitt Hopkins syndrome IND and Phase 2 trial
|
|
muzza111
|
30 |
15K |
4 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
30
|
15K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
10K |
4.5M |
22 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
10K
|
4.5M
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Neuren: Upcoming Catalysts 2022-23
|
|
muzza111
|
11 |
6.2K |
2 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
11
|
6.2K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2021 Results - a transformational year for Neuren
|
|
muzza111
|
75 |
34K |
23 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
75
|
34K
|
23
|
|
ASX - By Stock
|
AKE |
Re:
Allkem General Discussion
|
|
muzza111
|
5.1K |
2.3M |
1 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
5.1K
|
2.3M
|
1
|
|
ASX - By Stock
|
PLS |
Re:
When is $2,00 Party ?
|
|
muzza111
|
1.1K |
523K |
4 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
1.1K
|
523K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Covid Update
|
|
muzza111
|
7 |
3.1K |
2 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
7
|
3.1K
|
2
|
|
ASX - By Stock
|
LYC |
Re:
LYC future market cap and milestones
|
|
muzza111
|
61 |
25K |
6 |
18/04/21 |
18/04/21 |
ASX - By Stock
|
61
|
25K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
new trial Trofinetide
|
|
muzza111
|
49 |
21K |
7 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
49
|
21K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Bot controllers at work ?
|
|
muzza111
|
25 |
9.7K |
1 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
25
|
9.7K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Successful Phase 1 trial for Neuren's NNZ-2591
|
|
muzza111
|
22 |
9.2K |
8 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
22
|
9.2K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
2021
|
|
muzza111
|
44 |
23K |
2 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
44
|
23K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
muzza111
|
467 |
2.3M |
6 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
467
|
2.3M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Tightly Spring Now.
|
|
muzza111
|
117 |
95K |
3 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
117
|
95K
|
3
|
|